Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/24872
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Raine, Tim | - |
dc.contributor.author | Verstockt, Bram | - |
dc.contributor.author | De Cruz, Peter P | - |
dc.date | 2020-09 | - |
dc.date.accessioned | 2020-09-28T23:22:22Z | - |
dc.date.available | 2020-09-28T23:22:22Z | - |
dc.date.issued | 2020-09 | - |
dc.identifier.citation | The Lancet. Gastroenterology & Hepatology 2020; 5(9): 794-796 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/24872 | - |
dc.language.iso | eng | |
dc.title | Immune therapies in ulcerative colitis: are we beyond anti-TNF yet? | en |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | The Lancet. Gastroenterology & Hepatology | en |
dc.identifier.affiliation | Department of Gastroenterology, Cambridge University Teaching Hospitals NHS Foundation Trust, Cambridge, UK | en |
dc.identifier.affiliation | Department of Gastroenterology and Hepatology, University Hospitals Leuven and Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID-IBD), KU Leuven, Leuven, Belgium | en |
dc.identifier.affiliation | Gastroenterology and Hepatology | en |
dc.identifier.doi | 10.1016/S2468-1253(20)30210-7 | en |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 32818453 | |
local.name.researcher | De Cruz, Peter P | |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Gastroenterology and Hepatology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.